“Onset of Clinical Response With Deucravacitinib in Patients With Moderate to Severe Scalp Psoriasis: A Post Hoc Analysis of the Phase 3b 4 PSORIATYK SCALP Trial”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 2, Mar. 2025, p. s539, https://doi.org/10.25251/skin.10.supp.539.